Kara L. O’Brien

发表

Adenovirus-Specific Immunity Following Immunization with an Ad5 HIV-1 Vaccine Candidate in Humans

M. Betts, M. Lifton, J. Shiver, 2009, Nature Medicine.

Immune Control of an SIV Challenge by a T Cell-Based Vaccine in Rhesus Monkeys

D. Montefiori, K. Mansfield, G. Landucci, 2008, Nature.

Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine against Simian Immunodeficiency Virus Challenge in Rhesus Monkeys

S. Self, D. Montefiori, K. Mansfield, 2009, Journal of Virology.

Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

K. Mansfield, M. Havenga, A. Lemckert, 2007, Journal of Virology.

Age Dependence of Adenovirus-Specific Neutralizing Antibody Titers in Individuals from Sub-Saharan Africa

P. Jeena, G. Weverling, M. Havenga, 2006, Journal of Clinical Microbiology.

Contributions of Mamu-A*01 Status and TRIM5 Allele Expression, But Not CCL3L Copy Number Variation, to the Control of SIVmac251 Replication in Indian-Origin Rhesus Monkeys

D. Goldstein, B. Haynes, R. Gelman, 2010, PLoS genetics.

Mosaic HIV-1 Vaccines Expand the Breadth and Depth of Cellular Immune Responses in Rhesus Monkeys

Bette Korber, Michael S. Seaman, James J. Szinger, 2010, Nature Medicine.

Mucosal Trafficking of Vector-Specific CD4+ T Lymphocytes following Vaccination of Rhesus Monkeys with Adenovirus Serotype 5

K. Mansfield, D. Barouch, J. Whitney, 2010, Journal of Virology.

Mucosal Trafficking of Vector-Specific CD4+ T Lymphocytes following Vaccination of Rhesus Monkeys with Adenovirus Serotype 5

K. Mansfield, D. Barouch, J. Whitney, 2010, Journal of Virology.